agilon health director receives RSU stock grant
McLoughlin Karen reported acquisition or exercise transactions in this Form 4 filing. agilon health, inc. director Karen McLoughlin reported receiving an equity award of 2,133 shares of common stock in the form of restricted stock units.
Rhea-AI Filing Summary
McLoughlin Karen reported acquisition or exercise transactions in this Form 4 filing.
agilon health, inc. director Karen McLoughlin reported receiving an equity award of 2,133 shares of common stock in the form of restricted stock units. These units vest in full on June 2, 2027, if she continues serving as a director through that date.
After giving effect to a 1-for-25 reverse stock split effective March 30, 2026, her beneficial ownership, including restricted stock units, totals 8,207 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,133 | $0.00 | $0.00 |
Footnotes (3)
- F1. Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director.
- F2. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.
- F3. Includes restricted stock units.
Key Figures
Key Terms
restricted stock units financial
reverse stock split financial
beneficially owned financial
equity compensation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did agilon health (AGL) director Karen McLoughlin report on this Form 4?
When do Karen McLoughlin’s agilon health (AGL) restricted stock units vest?
Was Karen McLoughlin’s agilon health (AGL) equity award affected by a reverse stock split?
Is this agilon health (AGL) Form 4 a stock purchase or sale by Karen McLoughlin?
AI-generated analysis. How Rhea-AI works. Not financial advice.